Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

965 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Longitudinal follow-up of patients with thalassaemia intermedia who started transfusion therapy in adulthood: a cohort study.
Ricchi P, Meloni A, Pistoia L, Spasiano A, Rita Gamberini M, Maggio A, Gerardi C, Messina G, Campisi S, Allò M, Renne S, Righi R, Midiri M, Positano V, Filosa A, Pepe A. Ricchi P, et al. Among authors: messina g. Br J Haematol. 2020 Oct;191(1):107-114. doi: 10.1111/bjh.16753. Epub 2020 May 19. Br J Haematol. 2020. PMID: 32427352 Free article.
The Close Link of Pancreatic Iron With Glucose Metabolism and With Cardiac Complications in Thalassemia Major: A Large, Multicenter Observational Study.
Pepe A, Pistoia L, Gamberini MR, Cuccia L, Peluso A, Messina G, Spasiano A, Allò M, Bisconte MG, Putti MC, Casini T, Dello Iacono N, Celli M, Vitucci A, Giuliano P, Peritore G, Renne S, Righi R, Positano V, De Sanctis V, Meloni A. Pepe A, et al. Among authors: messina g. Diabetes Care. 2020 Nov;43(11):2830-2839. doi: 10.2337/dc20-0908. Epub 2020 Sep 4. Diabetes Care. 2020. PMID: 32887708
National networking in rare diseases and reduction of cardiac burden in thalassemia major.
Pepe A, Pistoia L, Gamberini MR, Cuccia L, Lisi R, Cecinati V, Maggio A, Sorrentino F, Filosa A, Rosso R, Messina G, Missere M, Righi R, Renne S, Vallone A, Dalmiani S, Positano V, Midiri M, Meloni A. Pepe A, et al. Among authors: messina g. Eur Heart J. 2022 Jul 7;43(26):2482-2492. doi: 10.1093/eurheartj/ehab851. Eur Heart J. 2022. PMID: 34907420
Relationship between pancreatic iron overload, glucose metabolism and cardiac complications in sickle cell disease: An Italian multicentre study.
Pistoia L, Meloni A, Allò M, Spasiano A, Messina G, Sorrentino F, Gamberini MR, Ermini A, Renne S, Fina P, Peritore G, Positano V, Pepe A, Cademartiri F. Pistoia L, et al. Among authors: messina g. Eur J Haematol. 2022 Sep;109(3):289-297. doi: 10.1111/ejh.13809. Epub 2022 Jul 8. Eur J Haematol. 2022. PMID: 35690882
Genotypic groups as risk factors for cardiac magnetic resonance abnormalities and complications in thalassemia major: a large, multicentre study.
Pistoia L, Meloni A, Ricchi P, Filosa A, Lisi R, Maggio A, Rosso R, Messina G, Iacono ND, Cuccia L, Campisi S, Missere M, Midiri M, Vallone A, Renne S, Schicchi N, Righi R, Mangione M, Positano V, Pepe A. Pistoia L, et al. Among authors: messina g. Blood Transfus. 2021 Mar;19(2):168-176. doi: 10.2450/2020.0023-20. Epub 2020 Jul 22. Blood Transfus. 2021. PMID: 33000750 Free PMC article.
The use of hydroxyurea in the real life of MIOT network: an observational study.
Ricchi P, Meloni A, Rigano P, Pistoia L, Spasiano A, Allò M, Messina G, Quarta A, Rosso R, Quota A, Filosa A, Maggio A, Pepe A. Ricchi P, et al. Among authors: messina g. Expert Opin Drug Saf. 2022 Nov;21(11):1433-1440. doi: 10.1080/14740338.2022.2064980. Epub 2022 Apr 17. Expert Opin Drug Saf. 2022. PMID: 35435090
A Concise Review on the Frequency, Major Risk Factors and Surveillance of Hepatocellular Carcinoma (HCC) in β-Thalassemias: Past, Present and Future Perspectives and the ICET-A Experience.
De Sanctis V, Soliman AT, Daar S, Alansary N, Kattamis A, Skafida M, Galati MC, Christou S, Campisi S, Messina G, Yassin MA, Canatan D, Di Maio S, Al Jaouni S, Raiola G, Karimi M, Kaleva V, Kakkar S, Mariannis D, Kattamis C. De Sanctis V, et al. Among authors: messina g. Mediterr J Hematol Infect Dis. 2020 Jan 1;12(1):e2020006. doi: 10.4084/MJHID.2020.006. eCollection 2020. Mediterr J Hematol Infect Dis. 2020. PMID: 31934316 Free PMC article. Review.
The The use of oral glucose-lowering agents (GLAs) in β-thalassemia patients with diabetes: Preliminary data from a retrospective study of ICET-A Network.
De Sanctis V, Soliman A, Tzoulis P, Daar S, Kattamis A, Delaporta P, Karimi M, Yassin MA, Zarei T, Saki F, Sapunarova K, Banchev A, Galati MC, Raiola G, Messina G, Campisi S, Kattamis C. De Sanctis V, et al. Among authors: messina g. Acta Biomed. 2022 May 11;93(2):e2022162. doi: 10.23750/abm.v93i2.12056. Acta Biomed. 2022. PMID: 35546014 Free PMC article.
965 results